Efficacy and safety of anti-Tumor Necrosis Factor-α biosimilars in Juvenile Idiopathic Arthritis - a systematic review and meta-analysis

Junjie Huang, Kai Liang Teh, Chunliang Chen, Lena Das, Thaschawee Arkachaisri

Open source

DOI
10.1016/j.semarthrit.2025.152792
Published
2025-10
Container
Seminars in Arthritis and Rheumatism
Publisher
Elsevier BV
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.semarthrit.2025.152792,
  title = {Efficacy and safety of anti-Tumor Necrosis Factor-α biosimilars in Juvenile Idiopathic Arthritis - a systematic review and meta-analysis},
  author = {Junjie Huang and Kai Liang Teh and Chunliang Chen and Lena Das and Thaschawee Arkachaisri},
  year = {2025},
  journal = {Seminars in Arthritis and Rheumatism},
  doi = {10.1016/j.semarthrit.2025.152792},
  url = {https://doi.org/10.1016/j.semarthrit.2025.152792}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of anti-Tumor Necrosis Factor-α biosimilars in Juvenile Idiopathic Arthritis - a systematic review and meta-analysis
AU  - Junjie Huang
AU  - Kai Liang Teh
AU  - Chunliang Chen
AU  - Lena Das
AU  - Thaschawee Arkachaisri
PY  - 2025
JO  - Seminars in Arthritis and Rheumatism
DO  - 10.1016/j.semarthrit.2025.152792
UR  - https://doi.org/10.1016/j.semarthrit.2025.152792
ER  - 

APA

Huang, J., Teh, K. L., Chen, C., Das, L., & Arkachaisri, T. (2025). Efficacy and safety of anti-Tumor Necrosis Factor-α biosimilars in Juvenile Idiopathic Arthritis - a systematic review and meta-analysis. Seminars in Arthritis and Rheumatism. https://doi.org/10.1016/j.semarthrit.2025.152792

Source records